Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis

Objective: The purpose of this study was to evaluate the efficacy and safety of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors for the treatment of metastatic urothelial carcinoma (mUC). Methods: A literature search was conducted of PubMed, EMBASE, and the Cochrane Library an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Pei-Fei, Wang, Ping-Yu, Peng, Tzu-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670843/
https://www.ncbi.nlm.nih.gov/pubmed/37999142
http://dx.doi.org/10.3390/curroncol30110722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670843/
https://www.ncbi.nlm.nih.gov/pubmed/37999142
http://dx.doi.org/10.3390/curroncol30110722

Ejemplares similares